Cytokine signatures in hereditary fever syndromes (HFS)

被引:15
作者
Ibrahim, Jose Noel [1 ,2 ,3 ]
Jeru, Isabelle [4 ]
Lecron, Jean-Claude [1 ,2 ]
Medlej-Hashim, Myrna [3 ]
机构
[1] Univ Poitiers, LITEC, EA4331, F-86022 Poitiers, France
[2] CHU Poitiers, F-86022 Poitiers, France
[3] Lebanese Univ, Fac Sci 2, BP 90656, Jdeidet El Metn, Lebanon
[4] Hop St Antoine, AP HP, Lab Common Biol & Genet Mol, F-75012 Paris, France
关键词
Hereditary fever syndromes; Cytokines; Serum; PBMC; ex vivo; Transcript; FAMILIAL MEDITERRANEAN FEVER; INTERLEUKIN-1 RECEPTOR ANTAGONIST; PERIODIC SYNDROME TRAPS; MEVALONATE KINASE-DEFICIENCY; NLRP3 INFLAMMASOME ACTIVATION; BLOOD MONONUCLEAR-CELLS; RICH REPEAT DOMAIN; HYPERIMMUNOGLOBULINEMIA-D; CASPASE-1; AUTOPROTEOLYSIS; AUTOINFLAMMATORY DISEASES;
D O I
10.1016/j.cytogfr.2016.11.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary fever syndromes (HFS) include a group of disorders characterized by recurrent self-limited episodes of fever accompanied by inflammatory manifestations occurring in the absence of infection or autoimmune reaction. Advances in the genetics of HFS have led to the identification of new gene families and pathways involved in the regulation of inflammation and innate immunity. The key role of several cytokine networks in the pathogenesis of HFS has been underlined by several groups, and supported by the rapid response of patients to targeted cytokine blocking therapies. This can be due to the direct effect of cytokine overproduction or to an absence of receptor antagonist resulting in dysbalance of downstream pro- and anti-inflammatory cytokine networks. The aim of this study was to present an overview and to discuss the major concepts regarding the cellular and molecular immunology of HFS, with a particular focus on their specific cytokine signatures and physiopathological implications. Based on their molecular and cellular mechanisms, HFS have been classified into intrinsic and extrinsic IL-1 beta activation disorders or inflammasomopathies, and protein misfolding disorders. This review integrates all recent data in an updated classification of HFS. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:19 / 34
页数:16
相关论文
共 182 条
  • [1] Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes
    Aganna, E
    Hammond, L
    Hawkins, PN
    Aldea, A
    McKee, SA
    van Amstel, HKP
    Mischung, C
    Kusuhara, K
    Saulsbury, FT
    Lachmann, HJ
    Bybee, A
    McDermott, EM
    La Regina, M
    Arostegui, JI
    Campistol, JM
    Worthington, S
    High, KP
    Molloy, MG
    Baker, N
    Bidwell, JL
    Castañer, JL
    Whiteford, ML
    Janssens-Korpola, PL
    Manna, R
    Powell, RJ
    Woo, P
    Solis, P
    Minden, K
    Frenkel, J
    Yagüe, J
    Mirakian, RM
    Hitman, GA
    McDermott, MF
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : 2632 - 2644
  • [2] De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID) -: A new member of the expanding family of pyrin-associated autoinflammatory diseases
    Aksentijevich, I
    Nowak, M
    Mallah, M
    Chae, JJ
    Watford, WT
    Hofmann, SR
    Stein, L
    Russo, R
    Goldsmith, D
    Dent, P
    Rosenberg, HF
    Austin, F
    Remmers, EF
    Balow, JE
    Rosenzweig, S
    Komarow, H
    Shoham, NG
    Wood, G
    Jones, J
    Mangra, N
    Carrero, H
    Adams, BS
    Moore, TL
    Schikler, K
    Hoffman, H
    Lovell, DJ
    Lipnick, R
    Barron, K
    O'Shea, JJ
    Kastner, DL
    Goldbach-Mansky, R
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3340 - 3348
  • [3] Aksentijevich I, 1997, CELL, V90, P797
  • [4] Mutational analysis in neonatal-onset multisystem innammatory disease: comment on the articles by Frenkel et al and Saito et al
    Aksentijevich, Ivona
    Remmers, Elaine F.
    Goldbach-Mansky, Raphaela
    Reiff, Andreas
    Kastner, Daniel L.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2703 - 2704
  • [5] An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
    Aksentijevich, Ivona
    Masters, Seth L.
    Ferguson, Polly J.
    Dancey, Paul
    Frenkel, Joost
    van Royen-Kerkhoff, Annet
    Laxer, Ron
    Tedgard, Ulf
    Cowen, Edward W.
    Pham, Tuyet-Hang
    Booty, Matthew
    Estes, Jacob D.
    Sandler, Netanya G.
    Plass, Nicole
    Stone, Deborah L.
    Turner, Maria L.
    Hill, Suvimol
    Butman, John A.
    Schneider, Rayfel
    Babyn, Paul
    El-Shanti, Hatem I.
    Pope, Elena
    Barron, Karyl
    Bing, Xinyu
    Laurence, Arian
    Lee, Chyi-Chia R.
    Chapelle, Dawn
    Clarke, Gillian I.
    Ohson, Kamal
    Nicholson, Marc
    Gadina, Massimo
    Yang, Barbara
    Korman, Benjamin D.
    Gregersen, Peter K.
    van Hagen, P. Martin
    Hak, A. Elisabeth
    Huizing, Marjan
    Rahman, Proton
    Douek, Daniel C.
    Remmers, Elaine F.
    Kastner, Daniel L.
    Goldbach-Mansky, Raphaela
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) : 2426 - 2437
  • [6] NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling
    Allen, Irving C.
    Wilson, Justin E.
    Schneider, Monika
    Lich, John D.
    Roberts, Reid A.
    Arthur, Janelle C.
    Woodford, Rita-Marie T.
    Davis, Beckley K.
    Uronis, Joshua M.
    Herfarth, Hans H.
    Jobin, Christian
    Rogers, Arlin B.
    Ting, Jenny P. -Y.
    [J]. IMMUNITY, 2012, 36 (05) : 742 - 754
  • [7] Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever
    Alpay, Nilufer
    Sumnu, Abdullah
    Caliskan, Yasar
    Yazici, Halil
    Turkmen, Aydin
    Gul, Ahmet
    [J]. RHEUMATOLOGY INTERNATIONAL, 2012, 32 (10) : 3277 - 3279
  • [8] A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset
    Altiok, Ender
    Aksoy, Figen
    Perk, Yildiz
    Taylan, Fulya
    Kim, Peter W.
    Ilikkan, Barbaros
    Asal, Gulten Turkkani
    Goldbach-Mansky, Raphaela
    Sanal, Ozden
    [J]. CLINICAL IMMUNOLOGY, 2012, 145 (01) : 77 - 81
  • [9] The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
    Martinon, F
    Burns, K
    Tschopp, J
    [J]. MOLECULAR CELL, 2002, 10 (02) : 417 - 426
  • [10] The balance between IL-1 and IL-1Ra in disease
    Arend, WR
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) : 323 - 340